TransMedics Group, Inc. (TMDX)
USD 70.96
(-2.94%)
USD 70.96
(-2.94%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 182.82 Million USD | 58.73% |
| 2022 | 96.7 Million USD | 59.62% |
| 2021 | 60.58 Million USD | 40.84% |
| 2020 | 43.01 Million USD | -1.03% |
| 2019 | 43.46 Million USD | 67.36% |
| 2018 | 25.97 Million USD | 15.1% |
| 2017 | 22.56 Million USD | -5.01% |
| 2016 | 23.75 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 56.65 Million USD | 19.42% |
| 2024 Q1 | 47.44 Million USD | 4.68% |
| 2024 Q3 | 56.92 Million USD | 0.47% |
| 2023 Q3 | 68.99 Million USD | 83.27% |
| 2023 Q4 | 45.32 Million USD | -34.31% |
| 2023 Q1 | 30.85 Million USD | 12.27% |
| 2023 Q2 | 37.64 Million USD | 22.01% |
| 2023 FY | 153.5 Million USD | 58.73% |
| 2022 Q1 | 21.47 Million USD | 17.25% |
| 2022 FY | 96.7 Million USD | 59.62% |
| 2022 Q4 | 27.48 Million USD | 16.16% |
| 2022 Q3 | 23.65 Million USD | -1.81% |
| 2022 Q2 | 24.09 Million USD | 12.21% |
| 2021 Q2 | 15.45 Million USD | 36.57% |
| 2021 Q1 | 11.31 Million USD | 5.54% |
| 2021 FY | 60.58 Million USD | 40.84% |
| 2021 Q4 | 18.31 Million USD | 18.17% |
| 2021 Q3 | 15.49 Million USD | 0.27% |
| 2020 Q3 | 9.64 Million USD | -1.25% |
| 2020 Q1 | 12.87 Million USD | 3.55% |
| 2020 FY | 43.01 Million USD | -1.03% |
| 2020 Q4 | 10.72 Million USD | 11.15% |
| 2020 Q2 | 9.77 Million USD | -24.13% |
| 2019 Q4 | 12.43 Million USD | 8.53% |
| 2019 Q2 | 11.03 Million USD | 29.33% |
| 2019 Q1 | 8.53 Million USD | 8.59% |
| 2019 FY | 43.46 Million USD | 67.36% |
| 2019 Q3 | 11.45 Million USD | 3.81% |
| 2018 Q3 | 6.07 Million USD | -4.17% |
| 2018 Q2 | 6.33 Million USD | 11.04% |
| 2018 Q1 | 5.7 Million USD | 13.99% |
| 2018 Q4 | 7.86 Million USD | 29.47% |
| 2018 FY | 25.97 Million USD | 15.1% |
| 2017 Q3 | 5.11 Million USD | -18.56% |
| 2017 FY | 22.56 Million USD | -5.01% |
| 2017 Q2 | 6.27 Million USD | 4.28% |
| 2017 Q1 | 6.01 Million USD | 0.0% |
| 2017 Q4 | 5 Million USD | -2.09% |
| 2016 FY | 23.75 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acutus Medical, Inc. | 11.22 Million USD | -1528.831% |
| Cerus Corporation | 143.15 Million USD | -27.708% |
| OrthoPediatrics Corp. | 137.01 Million USD | -33.427% |
| PetVivo Holdings, Inc. | 11.36 Million USD | -1509.208% |
| Talis Biomedical Corporation | 67.18 Million USD | -172.11% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | -632.863% |
| Inogen, Inc. | 236.08 Million USD | 22.562% |
| Spectral AI, Inc. | 20.86 Million USD | -776.246% |
| Nano-X Imaging Ltd. | 55.99 Million USD | -226.482% |
| CVRx, Inc. | 76.14 Million USD | -140.104% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -5081.979% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | -1363.848% |
| Orthofix Medical Inc. | 667.42 Million USD | 72.608% |
| Venus Concept Inc. | 80.47 Million USD | -127.173% |
| Accelerate Diagnostics, Inc. | 56.57 Million USD | -223.129% |
| Bioventus Inc. | 409.91 Million USD | 55.401% |
| BrainsWay Ltd. | 28.01 Million USD | -552.509% |
| Envoy Medical, Inc. | 17.89 Million USD | -921.455% |
| electroCore, Inc. | 32.03 Million USD | -470.76% |
| IceCure Medical Ltd | 16.87 Million USD | -983.314% |
| Lucid Diagnostics Inc. | 42.43 Million USD | -330.854% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | -936.804% |
| MaxCyte, Inc. | 84.84 Million USD | -115.475% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | -1372.957% |
| Nexalin Technology, Inc. | 5.78 Million USD | -3062.234% |
| PAVmed Inc | 64.82 Million USD | -182.012% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | -257.923% |
| RxSight, Inc. | 103.85 Million USD | -76.042% |
| Sight Sciences, Inc. | 126.44 Million USD | -44.58% |
| SI-BONE, Inc. | 156.35 Million USD | -16.929% |
| TELA Bio, Inc. | 84.18 Million USD | -117.159% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | -160.963% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | 10.103% |
| LivaNova PLC | 843.54 Million USD | 78.327% |
| 908 Devices Inc. | 68.08 Million USD | -168.537% |
| Alphatec Holdings, Inc. | 483.59 Million USD | 62.196% |
| Nemaura Medical Inc. | 7.13 Million USD | -2460.934% |
| NeuroPace, Inc. | 75.29 Million USD | -142.802% |
| LENSAR, Inc. | 33.33 Million USD | -448.416% |
| Apyx Medical Corporation | 51.01 Million USD | -258.344% |
| Cutera, Inc. | 197.72 Million USD | 7.538% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | -637.743% |
| BioSig Technologies, Inc. | 28.53 Million USD | -540.799% |
| Anika Therapeutics, Inc. | 191.47 Million USD | 4.52% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | -406.988% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | 78.142% |
| Axonics, Inc. | 270.2 Million USD | 32.34% |
| Outset Medical, Inc. | 198.77 Million USD | 8.024% |
| IRIDEX Corporation | 31.81 Million USD | -474.653% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | -1.443% |
| IRadimed Corporation | 30.12 Million USD | -506.915% |
| Tivic Health Systems, Inc. | 8.53 Million USD | -2042.757% |
| INVO Bioscience, Inc. | 7.85 Million USD | -2227.941% |
| Telesis Bio, Inc. | 63.48 Million USD | -187.955% |
| Viemed Healthcare, Inc. | 98.45 Million USD | -85.693% |
| Varex Imaging Corporation | 224.8 Million USD | 18.674% |
| Quipt Home Medical Corp. | 148.66 Million USD | -22.973% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -1459.498% |
| Pulmonx Corporation | 112.68 Million USD | -62.237% |
| Dynatronics Corporation | 9.9 Million USD | -1745.171% |
| Modular Medical, Inc. | 17.52 Million USD | -942.957% |
| ReShape Lifesciences Inc. | 20.18 Million USD | -805.632% |
| Semler Scientific, Inc. | 38.94 Million USD | -369.443% |
| InMode Ltd. | 215.68 Million USD | 15.236% |
| Bruker Corporation | 1.07 Billion USD | 83.016% |
| Cytosorbents Corporation | 48.33 Million USD | -278.221% |
| DexCom, Inc. | 1.69 Billion USD | 89.19% |
| Align Technology, Inc. | 2.07 Billion USD | 91.197% |
| Viveve Medical, Inc. | 22.17 Million USD | -724.516% |
| ZimVie Inc. | 275.12 Million USD | 33.55% |
| Movano Inc. | 29.69 Million USD | -515.763% |
| Cytek Biosciences, Inc. | 137.27 Million USD | -33.182% |
| Nexalin Technology, Inc. | 5.78 Million USD | -3062.234% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -5081.979% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | 69.577% |
| Profound Medical Corp. | 33.6 Million USD | -444.056% |
| Insulet Corporation | 939.9 Million USD | 80.549% |
| enVVeno Medical Corporation | 25.23 Million USD | -624.384% |
| Surmodics, Inc. | 98.69 Million USD | -85.234% |
| iCAD, Inc. | 22.22 Million USD | -722.587% |
| Nuwellis, Inc. | 22.61 Million USD | -708.473% |
| Biotricity, Inc. | 17.18 Million USD | -963.863% |
| iRhythm Technologies, Inc. | 445.88 Million USD | 58.999% |
| Aethlon Medical, Inc. | 12.27 Million USD | -1389.064% |
| InspireMD, Inc. | 22.95 Million USD | -696.601% |
| PAVmed Inc. | 64.82 Million USD | -182.012% |
| BIOLASE, Inc. | 34.66 Million USD | -427.452% |
| Beyond Air, Inc. | 61.7 Million USD | -196.305% |
| FONAR Corporation | 28.6 Million USD | -539.126% |
| AxoGen, Inc. | 149.33 Million USD | -22.422% |
| Vivani Medical, Inc. | 26.96 Million USD | -577.99% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | -3.234% |
| Inari Medical, Inc. | 448.59 Million USD | 59.246% |
| UFP Technologies, Inc. | 58.08 Million USD | -214.724% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -3610.123% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | -2793.505% |
| Tenon Medical, Inc. | 16.96 Million USD | -977.44% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -2372.88% |
| Co-Diagnostics, Inc. | 44.1 Million USD | -314.531% |
| AdaptHealth Corp. | 1.07 Billion USD | 83.04% |
| Sintx Technologies, Inc. | 15.2 Million USD | -1102.684% |
| NanoVibronix, Inc. | 4.97 Million USD | -3576.252% |
| Quanterix Corporation | 118.1 Million USD | -54.801% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -1459.498% |
| Sensus Healthcare, Inc. | 14.44 Million USD | -1165.891% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | 53.441% |
| ReWalk Robotics Ltd. | 28.06 Million USD | -551.416% |
| NeuroMetrix, Inc. | 11.09 Million USD | -1547.185% |
| Hyperfine, Inc. | 52.87 Million USD | -245.778% |
| Establishment Labs Holdings Inc. | 172 Million USD | -6.289% |
| Biomerica, Inc. | 6.97 Million USD | -2519.948% |
| Bone Biologics Corporation | 9.42 Million USD | -1839.055% |
| AVITA Medical, Inc. | 80.77 Million USD | -126.321% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | -1673.021% |
| Silk Road Medical, Inc | 186.35 Million USD | 1.898% |